Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma

  1. Richardson, P.G.
  2. Durie, B.G.
  3. Rosiñol, L.
  4. Mateos, M.-V.
  5. Dispenzieri, A.
  6. Moreau, P.
  7. Kumar, S.
  8. Raje, N.
  9. Munshi, N.
  10. Laubach, J.P.
  11. O’Gorman, P.
  12. O’Donnell, E.
  13. Voorhees, P.
  14. Facon, T.
  15. Bladé, J.
  16. Lonial, S.
  17. Perrot, A.
  18. Anderson, K.C.
Aldizkaria:
Haematologica

ISSN: 1592-8721,  0390-6078

Argitalpen urtea: 2023

Alea: 108

Zenbakia: 11

Orrialdeak: 2894-2912

Mota: Berrikuspena

DOI: 10.3324/HAEMATOL.2022.282624 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus